Biovac and IVI sign ground breaking deal for the manufacturing of OCV
Biovac signs deal with IVI to develop and manufacture oral cholera vaccine (OCV) for African and global markets.
List view / Grid view
Biovac signs deal with IVI to develop and manufacture oral cholera vaccine (OCV) for African and global markets.
US researchers discovered in a study in mice that augmented drug eliminates cancer cells without causing toxicity.
Sloan Kettering Institute (SKI) researchers have developed a new machete technique to slice into the cancer genome and study copy number alterations.
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
US researchers have uncovered the uncapped potential that gut-friendly bacteria has for improving treatments of inflammatory bowel disease (IBD).
South Korean researchers identified two saponins there were highly effective in blocking the ability of SARS-CoV-2 variants to enter cells.
A study has suggested that a new vaccine could prevent fentanyl from entering the brain, after showing success in rats.
US researchers, using a 3D neural tissue model, found that compounds from green tea and resveratrol could diminish Alzheimer’s amyloid plaques in lab tests, with no side effects.
The research has shown in high-resolution detail how certain lipids interact with pacemaker ion channels to enhance their activity.
Trinity researchers have discovered the secret to viral resistance, by screening women exposed to HCV.
In their study, the researchers from the University of Maryland School of Medicine found that the Nsp6 SARS-CoV-2 protein causes heart damage.
Researchers have found that beer hop compounds can inhibit the clumping of proteins associated with Alzheimer's disease.
A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defence mechanisms.
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
The College of American Pathologists has given accreditation to Altasciences’ clinical site in Los Angeles, California.